The Theranos debacle hasn't dissuaded retailers from partnering with labs. LabCorp & Walgreens Walgreens, Theranos's ex-retail partner, has moved on and entered into an agreement with another … [Read more...]
PRECISION MEDICINE
Market Trends: Lab-Retail Collaboration Remains Strong Despite Theranos Debacle
January 21, 2019
INDUSTRY BUZZ
Earnings Report: Top Payers Announce Q3 Earnings
January 7, 2019
The country's five largest commercial payers posted strong results for the third quarter of fiscal year 2018: COMPANY QUARTERLY REVENUES PERFORMANCE Total Q3* 2018 YOY Wall … [Read more...]
CUSTOMER SERVICE
Lab Leaders Have New Opportunities in the Age of Consumerism
October 30, 2018
The G2 Power Panel provided attendees at the 36th annual Lab Institute (Oct. 24-26; Washington, D.C.) an opportunity to learn how some of the nation's leading laboratories are navigating the current … [Read more...]
REVENUES
DX Earnings Report: Q2 Lab Earnings Stay Strong but Not Quite at Q1 Levels
September 4, 2018
Q2 is shaping up to be another strong quarter—albeit not as stellar as Q1. Salient trends: Big labs continue posting impressive organic growth even as they enjoy the surge of new revenues from … [Read more...]
SPECIAL FOCUS
Cost Avoidance vs Cost Savings: What’s the Difference?
August 31, 2018
By Jennifer Dawson, MHA, DLM (ASCP) bio As I work to spread awareness within the clinical laboratory community about the Cost of Poor Quality (COPQ) concept and its benefits as a method to … [Read more...]
EARNINGS
How to Avoid a Laboratory Audit
August 20, 2018
By Sean McSweeney bio Laboratory audits have a much harder impact on your lab than intended. As detailed by the NCBI, the audit's intent is to review and assess laboratory performance to … [Read more...]
PAMA
PAMA Unlocks Golden Age for Innovative Diagnostics
July 30, 2018
By Chance Scott bio The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition. When Congress … [Read more...]
REVENUES
DX Earnings Report: PAMA Cuts Make Little Dent on Q1 Lab Earnings
July 23, 2018
One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs. In fact, the recently published Q1 earnings … [Read more...]
REVENUES
Dx Earnings Report: Strong Q4 as Lab Companies End Year with a Bang
March 5, 2018
Big PAMA cuts may lay ahead in 2017, but the diagnostics industry had a robust 2017. While the entire year was strong, success was the most widespread in the fourth quarter with all but a few … [Read more...]
REVENUES
Dx Earnings Report: Strong Q3 Adds to Robust 2017 as PAMA Looms for 2018
December 5, 2017
Big labs continue to post impressive earnings. But the positive Q3 numbers may prove to be the calm before the PAMA storm—at least for major reference labs that generate significant revenues from … [Read more...]
